ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 2426 • ACR Convergence 2023

    The Role of β-catenin in Synovial Lining Fibroblast Differentiation

    Sonia Presti1, Gerald F.M. Watts1, Junning Case1, Zhu Zhu2, Teri Bowman1, Hung Nguyen1, Gabriel Nigrovic1, Ce Gao1, Kartik Bhamidipati1, Yuhong Li1, Suppawat Kongthong1, Fan Zhang3, Anna Helena Jonsson1, Accelerating Medicines Partnership Program (AMP RA/SLE) Network4, STARS BWH1, Michael Brenner5, Shideh Kazerounian1 and Kevin Wei5, 1Brigham and Women's Hospital, Boston, MA, 210x Genomics, St. Louis, MO, 3University of Colorado, Aurora, CO, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, Boston, MA, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: In healthy synovium, lining fibroblasts promote joint health by secreting proteoglycans that lubricate the joint cavity. In rheumatoid arthritis (RA), sublining fibroblasts undergo marked…
  • Abstract Number: 0310 • ACR Convergence 2023

    Implementing an Osteoarthritis Management Program to Deliver Guideline-Driven Care for Knee and Hip Osteoarthritis in a U.S. Academic Health System

    Kathryn Miller1, Divya Vundamati2, Linda Baier1, Roger Brown1, Tommy Yue Yu1 and Christie M. Bartels3, 1University of Wisconsin, Madison, WI, 2UW Health, Madison, WI, 3University of Wisconsin, School of Medicine and Public Health, Madison, WI

    Background/Purpose: To assess patient outcomes from an Osteoarthritis Management Program (OAMP) situated in an academic medical center.Methods: Eligibility for this open cohort study included adults…
  • Abstract Number: 0749 • ACR Convergence 2023

    Impact of Sprifermin on Denuded Areas of Subchondral Bone (dABs): A Post Hoc Analysis of the FORWARD Study

    Felix Eckstein1, Wolfgang Wirth2, Philip Conaghan3, Marc Hochberg4, Ali Guermazi5, Jade Andrade6, Luping Zhao6 and Niti Goel7, 1Paracelsus Medical University, Institute of Anatomy & Ludwig Boltzmann Institute, and Chondrometrics GmbH, Salzburg, Austria, 2Paracelsus Medical University, Institute of Anatomy & Ludwig Boltzmann Institute, and Chondrometrics GmbH, Freilassing, Germany, 3University of Leeds, Leeds, United Kingdom, 4University of Maryland School of Medicine, Baltimore, MD, 5Boston University, Boston, MA, 6TrialSpark, New York, NY, 7TrialSpark, Duke University, Durham, NC

    Background/Purpose: Sprifermin, recombinant human fibroblast growth factor 18 (rhFGF-18), is being investigated as a potential disease-modifying osteoarthritis drug. The Phase 2 FORWARD study demonstrated that…
  • Abstract Number: 0868 • ACR Convergence 2023

    Enhancing Oxidative Phosphorylation Through PDK2 Depletion Alleviates Cartilage Degradation in Surgically Induced Osteoarthritis

    Seungwoo Han1, Jin Han2, Yujung kim2, Yoonhee Kim2 and Donghwi Park3, 1Kyungpook national university hospital, Daegu, South Korea, 2Kyungpook National University, Daegu, South Korea, 3Daegu Fatima hospital, Daegu, South Korea

    Background/Purpose: Although chondrocytes rely primarily on glycolysis to meet their cellular energy needs, they have the metabolic flexibility to shift toward oxidative phosphorylation (OxPhos) in…
  • Abstract Number: 0885 • ACR Convergence 2023

    Mice Fed a Well-formulated Ketogenic Diet After OA Induction Develop Worse OA Outcomes and Increased Pain Sensitivity

    Montana Barrett1, Gabby Dyson2, Meeshal Khan3, Nicholas Hanebutt2, Cindy Miranda2, Leoni Schlupp2, Emmaline Holmlund2 and Matlock Jeffries2, 1Oklahoma State University, Guthrie, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: A ketogenic diet (KD) has beneficial effects in preclinical models of a variety of systemic autoimmune diseases. In this study, we set out to…
  • Abstract Number: 1195 • ACR Convergence 2023

    Relationship of Depth-Specific Subchondral Bone Mineral Density to MRI Cartilage Worsening: The Multicenter Osteoarthritis Study

    Jean Liew1, JD Johnston2, Gabriela Rabasa1, Beth Lewis3, John Lynch4, James Torner5 and Tuhina Neogi6, 1Boston University, Boston, MA, 2University of Saskatchewan, Saskatoon, SK, Canada, 3University of Alabama at Birimingham, Birmingham, AL, 4University of California San Francisco, San Francisco, CA, 5University of Iowa, Iowa City, IA, 6Boston University School of Medicine, Boston, MA

    Background/Purpose: While OA has been considered a disease of cartilage, early subchondral bone changes may precede cartilage abnormalities. Although higher systemic BMD has a known…
  • Abstract Number: 1798 • ACR Convergence 2023

    Association Between Knee Osteoarthritis and Mortality: A Serial Propensity Score-matched Cohort Study

    Sunggun Lee1, Minkyoung Oh2, Mi-Yeong Kim3, Minyoung Her1 and Seong-Ho Kim1, 1Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea, 2Department of pharmacology, Inje University College of Medicine, Busan, South Korea, 3Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea

    Background/Purpose: The association between symptomatic knee osteoarthritis (OA) and higher cardiovascular disease (CVD) mortality is well established; however, findings from previous studies that utilized regression…
  • Abstract Number: 1982 • ACR Convergence 2023

    Effect of Denosumab on Knee Pain and Bone Marrow Lesions in Symptomatic Knee Osteoarthritis

    Terence O'Neill1, Matthew Parkes1, Michael Bowes2, Richard Hodgson1 and David Felson3, 1University of Manchester, Manchester, United Kingdom, 2Imorphics, Manchester, United Kingdom, 3Boston University, Boston, MA

    Background/Purpose: There are currently no licensed therapies which reduce progression of knee OA. Current therapies focus on reducing pain, have limited effect, and some have…
  • Abstract Number: 2467 • ACR Convergence 2023

    Quadriceps Muscle Fat Composition but Not Muscle Energetics Is Associated with Knee Osteoarthritis: Initial Results from the Study of Muscle, Mobility, and Aging

    Giovanna Distefano1, Daniel Evans2, Peggy Cawthon2, John Lynch2, Thomas Link2, Philip Kramer3, Stephanie Harrison2, Bret Goodpaster4, Jane Cauley5, Theresa Mau2, Paul Coen4, Lauren Sparks4 and Nancy Lane6, 1AventisHealth, Orlando, FL, 2University of California San Francisco, San Francisco, CA, 3Wake Forest, Winston-Salem, NC, 4Aventis Health, Orlando, FL, 5University of Pittsburgh, Pittsburgh, PA, 6University of California, Hillsborough, CA

    Background/Purpose: Osteoarthritis (OA) remains the most common cause of joint pain and disability with age, and to date, effective treatments to reduce pain and slow…
  • Abstract Number: 0311 • ACR Convergence 2023

    Heterogeneity and Natural History of Medial Fixed Joint Space Width in Healthy Knees Among Women and Men: Data from Three Large Cohort Studies

    Kent Kwoh1, Erin Ashbeck2, Edward Bedrick1, Yvonne Golightly3, Zong-Ming Li1, Jean liew4, Amanda Nelson5, Tuhina Neogi6, Xiaoxiao Sun1 and Jeffrey Duryea7, 1University of Arizona, Tucson, AZ, 2University of Arizona Arthritis Center, Tucson, AZ, 3University of Nebraska Medical Center, Omaha, NE, 4Boston University, Boston, MA, 5University of North Carolina at Chapel Hill, Chapel Hill, NC, 6Boston University School of Medicine, Boston, MA, 7Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Radiographic joint space width (JSW) is commonly used to assess structural progression in randomized controlled trials and observational studies of knee osteoarthritis (KOA). No…
  • Abstract Number: 0756 • ACR Convergence 2023

    Validation of Quantitative Effusion-synovitis Volume Measured by Deep-learning: Data from the Osteoarthritis Initiative

    Banafshe Felfeliyan1, Stephanie Wichuk2, Abhilash Hareendranathan3, Janet Ronsky4 and Jacob Jaremko2, 1University of Alberta, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Radiology and Diagnostic Imaging, Edmonton, AB, Canada, 4University of Calgary, Calgary, AB, Canada

    Background/Purpose: Knee effusion-synovitis (ES) is an attractive target for therapeutic interventions in arthritis, since it is associated with stiffness, pain, and disease progression to arthroplasty.…
  • Abstract Number: 0869 • ACR Convergence 2023

    Clinical Impact of PTEN as a Marker for Diabetes-Associated Osteoarthritis

    Irene Lorenzo Gomez1, Uxía nogueira Recalde2, Christian García Domínguez1, Natividad Oreiro Villar3, Jose Antonio Pinto Tasende3, Mohit Kapoor4, Francisco J. Blanco3 and Beatriz Carames1, 1Unidad de Biología del Cartílago, Grupo de Reumatología, Instituto de Investigación Biomédica de A Coruña (iNIBIC), A Coruña, Spain, 2Unidad de Biología del Cartílago, Grupo de Reumatología, Instituto de Investigación Biomedica de A Coruña (iNIBIC), A Coruña, Spain, 3Rheumatology department, Complexo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC), A Coruña, Spain, 4Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, and Krembil Research Institute, University Health Network, Toronto, ON, Canada

    Background/Purpose: Defects in homeostatic mechanisms, such as autophagy, contribute to joint aging and Osteoarthritis (OA) and precede joint damage (1). OA is a complex and…
  • Abstract Number: 1006 • ACR Convergence 2023

    Use of Implementation Strategies to Promote Adherence of Knee Osteoarthritis Guidelines and Improve Patient Outcomes: A Systematic Review

    Michelle Ramirez1, Rebecca Fillipo1, Connor Drake1, Lesley Skalla2, Kelli Allen3, Amanda Nelson4 and Maggie Horn1, 1Duke University School of Medicine, Durham, NC, 2Duke University Medical Center Library & Archives, Durham, NC, 3University of North Carolina, Durham, NC, 4University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Despite the development of care models and practice guidelines the translation of knee osteoarthritis guidelines to practice remains suboptimal. Theoretically informed implementation strategies may…
  • Abstract Number: 1196 • ACR Convergence 2023

    Association of Long-Term Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) with Worsening Symptoms and Structural Changes of Knee Osteoarthritis: An Individual Patient Data Meta-Analysis of Cohort Studies

    Zubeyir Salis1 and Amanda Sainsbury2, 1The University of New South Wales, Kensington, Australia, 2The University of Western Australia, Crawley, Australia

    Background/Purpose: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are commonly prescribed for short-term management of symptoms of knee osteoarthritis (KOA), but they are often used long-term, and the…
  • Abstract Number: 1808 • ACR Convergence 2023

    Tobacco Smoking Reduces the Incidence and Delays the Progression of Knee Osteoarthritis: 10-year Retrospective Cohort Study Based on Korea National Health Insurance Service-Health Screening Database

    Junyong Park1, Minkook Son2, Sang Yeob Lee1, Wontae Chung1 and SungWon Lee1, 1Dong-A University Hospital, Busan, South Korea, 2Dong-A University, Busan, South Korea

    Background/Purpose: There are conflicting results about relationship between smoking and incidence of knee osteoarthritis (OA). The effect of smoking to preexisting knee OA has also…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 71
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology